“…Consequently, we used the crystal structure of the WASF regulatory complex site to identify small molecules that were predicted to interact with the WASF3 structure. The National Cancer Institute (NCI) diversity set VI, consisting of 1584 compounds, was used primarily because these molecules are generally well characterized, structurally diverse, and freely available [ 25 ]. The scoring algorithm in this in silico approach is based on molecular mechanics force fields that estimate the energy of the pose within the binding site.…”